BEGIN:VCALENDAR
PRODID:-//github.com/rianjs/ical.net//NONSGML ical.net 4.0//EN
VERSION:2.0
BEGIN:VEVENT
DESCRIPTION:With 5% of cancer drugs going into the clinic\, it is critical
  that oncology scientists invest in more translational and predictive mod
 els to de-risk the validation of novel targets\, predict therapeutic resp
 onse\, and support biomarker discovery\, particularly with such a high pr
 ice tag for clinical failure.\n\nThe 13th Tumour Models London Summit sta
 nds as the only industry-led meeting uniting pharma\, biotech\, and precl
 inical CROs from Europe to network and discuss new trends and innovations
  in tumour models. Attracting leading preclinical and translational exper
 tise\, this forum provides an essential platform for scientists and decis
 ion makers to hear about the latest innovations in in vivo and in vitro t
 umour modelling to de-risk their studies and accelerate their product's j
 ourney from lab to patient.\n\n \n\nDate and Time: On Wednesday December 
 04\, 2024 at 7:20 am to Thursday December 05\, 2024 at 5:10 pm\n
DTEND:20241205T171000
DTSTAMP:20260514T153517Z
DTSTART:20241204T072000
LOCATION:Millennium Hotel and Conference Centre Gloucester London\, 4-18 H
 arrington Gardens\, London\, England\, SW7 4LH\,
SEQUENCE:0
SUMMARY:With 5% of cancer drugs going into the clinic\, it is critical tha
 t oncology scientists invest in more translational and predictive models 
 to de-ris...
UID:ce7a1e5b-b659-45b5-a24b-3f02bf9ea072
END:VEVENT
END:VCALENDAR